BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cox RM, Sourimant J, Toots M, Yoon JJ, Ikegame S, Govindarajan M, Watkinson RE, Thibault P, Makhsous N, Lin MJ, Marengo JR, Sticher Z, Kolykhalov AA, Natchus MG, Greninger AL, Lee B, Plemper RK. Orally efficacious broad-spectrum allosteric inhibitor of paramyxovirus polymerase. Nat Microbiol 2020;5:1232-46. [PMID: 32661315 DOI: 10.1038/s41564-020-0752-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Schmitz KS, Lange MV, Gommers L, Handrejk K, Porter DP, Alabi CA, Moscona A, Porotto M, de Vries RD, de Swart RL. Repurposing an In Vitro Measles Virus Dissemination Assay for Screening of Antiviral Compounds. Viruses 2022;14:1186. [DOI: 10.3390/v14061186] [Reference Citation Analysis]
2 Avila-barrientos LP, Cofas-vargas LF, Agüero-chapin G, Hernández-garcía E, Ruiz-carmona S, Valdez-cruz NA, Trujillo-roldán M, Weber J, Ruiz-blanco YB, Barril X, García-hernández E. Computational Design of Inhibitors Targeting the Catalytic β Subunit of Escherichia coli FOF1-ATP Synthase. Antibiotics 2022;11:557. [DOI: 10.3390/antibiotics11050557] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chithelen J, Franke H, Länder N, Grafen A, Schneider-schaulies J. The Sphingolipid Inhibitors Ceranib-2 and SKI-II Reduce Measles Virus Replication in Primary Human Lymphocytes: Effects on mTORC1 Downstream Signaling. Front Physiol 2022;13:856143. [DOI: 10.3389/fphys.2022.856143] [Reference Citation Analysis]
4 Siering O, Cattaneo R, Pfaller CK. C Proteins: Controllers of Orderly Paramyxovirus Replication and of the Innate Immune Response. Viruses 2022;14:137. [PMID: 35062341 DOI: 10.3390/v14010137] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Shrestha N, Gall FM, Mathieu C, Hierweger MM, Brügger M, Alves MP, Vesin J, Banfi D, Kalbermatter D, Horvat B, Chambon M, Turcatti G, Fotiadis D, Riedl R, Plattet P. Highly Potent Host-Specific Small-Molecule Inhibitor of Paramyxovirus and Pneumovirus Replication with High Resistance Barrier. mBio 2021;:e0262121. [PMID: 34724816 DOI: 10.1128/mBio.02621-21] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Lee B, Ikegame S, Carmichael J, Wells H, Furler R, Acklin J, Chiu HP, Oguntuyo K, Cox R, Patel A, Kowdle S, Stevens C, Eckley M, Zhan S, Lim J, Hashiguchi T, Durigon EL, Schountz T, Epstein J, Plemper R, Daszak P, Anthony S. Zoonotic potential of a novel bat morbillivirus. Res Sq 2021:rs. [PMID: 34611656 DOI: 10.21203/rs.3.rs-926789/v1] [Reference Citation Analysis]
7 Shpichka A, Bikmulina P, Peshkova M, Heydari Z, Kosheleva N, Vosough M, Timashev P. Organoids in modelling infectious diseases. Drug Discov Today 2021:S1359-6446(21)00363-9. [PMID: 34418577 DOI: 10.1016/j.drudis.2021.08.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
8 Cox RM, Sourimant J, Govindarajan M, Natchus MG, Plemper RK. Therapeutic targeting of measles virus polymerase with ERDRP-0519 suppresses all RNA synthesis activity. PLoS Pathog 2021;17:e1009371. [PMID: 33621266 DOI: 10.1371/journal.ppat.1009371] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]